HUTCHMED (China) Ltd Files 6-K Report
Ticker: HMDCF · Form: 6-K · Filed: Dec 30, 2024 · CIK: 1648257
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
TL;DR
HUTCHMED (China) Ltd filed a 6-K on 12/30/24, confirming 20-F annual report filings.
AI Summary
HUTCHMED (China) Limited, formerly Hutchison China MediTech Ltd, filed a Form 6-K on December 30, 2024. This report is for the month of December 2024 and indicates the company files annual reports under Form 20-F. The company is incorporated in E9 and its principal executive offices are located in Hong Kong.
Why It Matters
This filing serves as an update for investors regarding the company's reporting status and administrative details, confirming its compliance with SEC regulations for foreign private issuers.
Risk Assessment
Risk Level: low — This is a routine administrative filing and does not contain new financial or operational information that would typically indicate increased risk.
Key Players & Entities
- HUTCHMED (China) Limited (company) — Registrant
- Hutchison China MediTech Ltd (company) — Former company name
- 20241230 (date) — Filing date and period of report
- 001-37710 (other) — SEC file number
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, used to furnish information which the issuer publishes or is required to publish outside of the United States.
When was this Form 6-K filed?
This Form 6-K was filed on December 30, 2024.
What is the company's principal executive office address?
The company's principal executive offices are located at 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong.
Does HUTCHMED (China) Limited file annual reports under Form 20-F or 40-F?
The filing indicates that HUTCHMED (China) Limited files annual reports under cover of Form 20-F.
What was the former name of HUTCHMED (China) Limited?
The former name of HUTCHMED (China) Limited was Hutchison China MediTech Ltd, with a date of name change on July 16, 2015.
Filing Stats: 159 words · 1 min read · ~1 pages · Grade level 13.1 · Accepted 2024-12-30 06:18:22
Filing Documents
- hcm-20241230x6k.htm (6-K) — 20KB
- hcm-20241230xex99d1.htm (EX-99.1) — 24KB
- hcm-20241230xex99d1001.gif (GRAPHIC) — 4KB
- 0001648257-24-000099.txt ( ) — 51KB
From the Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of December 2024 Commission File Number: 001-37710 HUTCHMED (CHINA) LIMITED (Translation of registrant's name into English) 48th Floor, Cheung Kong Center, 2 Queen's Road Central, Hong Kong (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F Form 40-F HUTCHMED (CHINA) LIMITED Form 6-K EXHIBIT INDEX Exhibit No. Description Exhibit 99.1 Announcement relating to blocklisting six monthly return 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. HUTCHMED (CHINA) LIMITED By: /s/ Johnny Cheng Name: Johnny Cheng Title: Chief Financial Officer Date: December 30, 2024 3